First Trust Exchange-Traded AlphaDEX Fund. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| REGENERON PHARMACEUTICALS INCREGN | 2.77% | $29.03M | 38,060 |
| UNIVERSAL HEALTH SERVICES INCUHS | 2.57% | $26.88M | 159,598 |
| SOLVENTUM CORPSOLV | 2.51% | $26.28M | 307,593 |
| BOSTON SCIENTIFIC CORPBSX | 2.48% | $25.98M | 556,019 |
| ZIMMER BIOMET HOLDINGS INCZBH | 2.47% | $25.89M | 275,654 |
| GUARDANT HEALTH INCGH | 2.45% | $25.62M | 158,176 |
| DAVITA INCDVA | 2.44% | $25.61M | 106,663 |
| PFIZER INCPFE | 2.35% | $24.65M | 985,502 |
| TENET HEALTHCARE CORPTHC | 2.30% | $24.13M | 94,714 |
| CIGNA GROUP (THE)CI | 2.29% | $24.02M | 86,083 |
| GLOBUS MEDICAL INCGMED | 2.26% | $23.66M | 300,351 |
| MEDLINE INCMDLN | 2.26% | $23.63M | 601,697 |
| NATERA INCNTRA | 2.23% | $23.41M | 87,424 |
| CORCEPT THERAPEUTICS INCCORT | 2.23% | $23.33M | 203,784 |
| CENTENE CORPCNC | 2.20% | $23.00M | 369,699 |
| AXSOME THERAPEUTICS INCAXSM | 2.02% | $21.14M | 96,954 |
| ENCOMPASS HEALTH CORPEHC | 1.86% | $19.47M | 175,295 |
| MEDTRONIC PLC | 1.85% | $19.34M | 226,501 |
| RESMED INCRMD | 1.83% | $19.18M | 90,923 |
| ZOETIS INCZTS | 1.82% | $19.06M | 246,575 |
| QIAGEN NV | 1.79% | $18.76M | 453,170 |
| HALOZYME THERAPEUTICS INCHALO | 1.78% | $18.69M | 226,384 |
| INCYTE CORPINCY | 1.78% | $18.68M | 156,306 |
| ARROWHEAD PHARMACEUTICALS INCARWR | 1.76% | $18.40M | 217,383 |
| NEUROCRINE BIOSCIENCES INCNBIX | 1.67% | $17.54M | 105,135 |
| ELEVANCE HEALTH INCELV | 1.64% | $17.22M | 45,819 |
| ELI LILLY & COMPANYLLY | 1.62% | $16.97M | 14,775 |
| UNITED THERAPEUTICS CORPUTHR | 1.62% | $16.93M | 32,701 |
| ASCENDIS PHARMA A/S | 1.55% | $16.20M | 66,435 |
| BRISTOL-MYERS SQUIBB COMPANYBMY | 1.54% | $16.14M | 247,112 |
| VIATRIS INCVTRS | 1.50% | $15.74M | 896,631 |
| LABCORP HOLDINGS INCLH | 1.50% | $15.72M | 50,851 |
| QUEST DIAGNOSTICS INCDGX | 1.49% | $15.65M | 67,178 |
| BECTON DICKINSON & COMPANYBDX | 1.49% | $15.58M | 94,088 |
| MEDPACE HOLDINGS INCMEDP | 1.48% | $15.52M | 26,886 |
| STERIS PLC | 1.47% | $15.44M | 67,620 |
| GE HEALTHCARE TECHNOLOGIES INCGEHC | 1.44% | $15.13M | 222,442 |
| GILEAD SCIENCES INCGILD | 1.40% | $14.67M | 112,700 |
| DOXIMITY INCDOCS | 1.37% | $14.36M | 686,526 |
| REVOLUTION MEDICINES INCRVMD | 1.36% | $14.26M | 76,029 |
| EXELIXIS INCEXEL | 1.32% | $13.88M | 261,689 |
| BIOGEN INCBIIB | 1.28% | $13.37M | 65,899 |
| IQVIA HOLDINGS INCIQV | 1.03% | $10.78M | 45,853 |
| ABBOTT LABORATORIESABT | 0.98% | $10.32M | 97,638 |
| VEEVA SYSTEMS INCVEEV | 0.97% | $10.17M | 49,923 |
| THERMO FISHER SCIENTIFIC INCTMO | 0.97% | $10.15M | 17,671 |
| CHEMED CORPCHE | 0.97% | $10.12M | 19,021 |
| BRIDGEBIO PHARMA INCBBIO | 0.91% | $9.53M | 118,952 |
| IONIS PHARMACEUTICALS INCIONS | 0.89% | $9.30M | 179,574 |
| AGILENT TECHNOLOGIES INCA | 0.88% | $9.23M | 66,697 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.